A detailed history of Virginia Retirement Systems Et Al transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Virginia Retirement Systems Et Al holds 9,400 shares of PTCT stock, worth $434,656. This represents 0.0% of its overall portfolio holdings.

Number of Shares
9,400
Previous 12,700 25.98%
Holding current value
$434,656
Previous $516,000 59.3%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Jan 02, 2024

SELL
$22.41 - $41.99 $73,953 - $138,567
-3,300 Reduced 25.98%
9,400 $210,000
Q2 2023

Aug 22, 2023

BUY
$40.4 - $59.1 $513,080 - $750,570
12,700 New
12,700 $516,000
Q4 2022

May 17, 2023

SELL
$33.53 - $54.79 $46,942 - $76,706
-1,400 Reduced 11.67%
10,600 $405 Million
Q3 2022

May 16, 2023

BUY
$41.85 - $53.85 $502,200 - $646,200
12,000 New
12,000 $602 Million
Q1 2021

Apr 30, 2021

SELL
$46.8 - $68.92 $205,920 - $303,248
-4,400 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$47.96 - $67.64 $211,024 - $297,616
4,400 New
4,400 $269,000
Q3 2020

Nov 12, 2020

SELL
$45.41 - $57.07 $217,967 - $273,936
-4,800 Closed
0 $0
Q2 2020

Aug 12, 2020

BUY
$42.56 - $54.98 $204,288 - $263,904
4,800 New
4,800 $244,000
Q4 2019

Jan 27, 2020

SELL
$32.22 - $50.07 $560,628 - $871,218
-17,400 Closed
0 $0
Q3 2019

Oct 22, 2019

SELL
$33.82 - $48.17 $23,674 - $33,719
-700 Reduced 3.87%
17,400 $588,000
Q1 2019

Apr 25, 2019

SELL
$28.09 - $39.49 $70,225 - $98,725
-2,500 Reduced 12.14%
18,100 $681,000
Q3 2018

Nov 02, 2018

SELL
$33.9 - $47.77 $935,640 - $1.32 Million
-27,600 Reduced 57.26%
20,600 $968,000
Q2 2018

Aug 03, 2018

BUY
$25.7 - $47.88 $1.24 Million - $2.31 Million
48,200 New
48,200 $1.63 Million

Others Institutions Holding PTCT

About PTC THERAPEUTICS, INC.


  • Ticker PTCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,541,000
  • Market Cap $3.31B
  • Description
  • PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...
More about PTCT
Track This Portfolio

Track Virginia Retirement Systems Et Al Portfolio

Follow Virginia Retirement Systems Et Al and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virginia Retirement Systems Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Virginia Retirement Systems Et Al with notifications on news.